TapewireFind a company

person · Reporting owner

Andreano Dominic J

Disclosed activity across 1 company

Tapewire entity
123500
SEC CIK
0001549694

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Pediatrix Medical Group, Inc.MD · Entity 4451EVP, General Counsel and SecySeptember 26, 2022September 28, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Pediatrix Medical Group, Inc.

Report date September 26, 2022 · Filed September 28, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect189,440 Reported balance After 2022-09-26 transaction · row 1
1 source row

Row 1 · 2022-09-26 · Tax withholding · Disposed 4,267 · Balance 189,440

F1: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 26, 2022 Filed Sep 28, 2022 21:00 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 4,267 $16.81 $71,728.27
Disclosure

SEC source: 0001209191-22-051470 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,440

F1 · shares: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:00 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 6,635 $23.47 $155,723.45
Disclosure

SEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 3

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,707

F4 · kind: Represents 6,635 restricted shares withheld for payment of taxes upon vesting of shares.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:00 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 29,412 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,342

F3 · kind: Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,706 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:00 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 29,412 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015586 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,930

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan.

F2 · balance_after: Includes 11,021 restricted shares granted pursuant to the Plan in connection with achievement in excess of target of specified performance-based criteria for the performance period from January 1, 2021 through December 31, 2021.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:36 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 27,552 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016882 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,497

F2 · kind: Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024, subject to the terms of the Plan.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:36 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 27,551 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016882 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,945

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 13,776 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2022, twenty-five percent (25%) on March 1, 2023 and fifty percent (50%) on March 1, 2024, subject to the terms of the Plan.

Read SEC document
September 26, 2020 Filed Sep 29, 2020 20:53 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantEmployee Stock Option (right to buy) · Derivative 96,000 $0.00 Strike: $16.14 $0.00
Disclosure

SEC source: 0001209191-20-052356 · doc4.xml · derivative · entry 2

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,000

Underlying: Common Stock · 96,000 shares

Expires 2023-12-26

F2 · derivative.exercise_date: Option to purchase shares of Common Stock awarded under the Plan that vests as follows: (A) 30,500 shares are exercisable if and when the Issuer's Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before the third anniversary of the grant date ("Performance End Date"); (B) 31,500 shares are exercisable if and when the Issuer's Common Stock closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 34,000 shares are exercisable if and when the Issuer's Common Stock price closes at $29 (or above) for any 40 consecutive trading days before the Performance End Date, provided that no option shares will vest prior to the one-year anniversary of the grant date.

F2 · derivative.expiration_date: Option to purchase shares of Common Stock awarded under the Plan that vests as follows: (A) 30,500 shares are exercisable if and when the Issuer's Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before the third anniversary of the grant date ("Performance End Date"); (B) 31,500 shares are exercisable if and when the Issuer's Common Stock closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 34,000 shares are exercisable if and when the Issuer's Common Stock price closes at $29 (or above) for any 40 consecutive trading days before the Performance End Date, provided that no option shares will vest prior to the one-year anniversary of the grant date.

Read SEC document
September 26, 2020 Filed Sep 29, 2020 20:53 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 21,686 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-052356 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,394

F1 · shares: Restricted shares of the Issuer's common stock ("Common Stock") granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"). Such shares vest as follows: (i) 10,843 shares vest on the second anniversary of the grant date and (ii) 10,843 shares vest on the third anniversary of the grant date, subject to the terms of the Plan.

Read SEC document
September 15, 2020 Filed Sep 17, 2020 21:01 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 22,000 $18.93 $416,424.80
Disclosure

SEC source: 0001209191-20-050955 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,708

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in fifty-one (51) separate transactions with prices ranging from $18.76 to $19.28 for an average weighted sale price of $18.9284. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this section.

Read SEC document
July 12, 2020 Filed Jul 15, 2020 00:17 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 32,413 $17.65 $572,089.45
Disclosure

SEC source: 0001209191-20-042446 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,708

F1 · shares: Represents shares withheld for the payment of taxes upon the vesting of shares of restricted stock previously reported.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 20:26 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 1,179 $15.53 $18,309.87
Disclosure

SEC source: 0001209191-20-034009 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,121

F1 · kind: Represents 1,179 shares withheld for payment of taxes upon vesting of shares previously reported.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 21:48 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionRestricted Shares Units · Derivative 9,828 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015297 · doc4.xml · derivative · entry 3

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,828 shares

Expires 2027-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted Shares Units granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan.

F4 · derivative.exercise_price: Each Restricted Shares Units represents the equivalent of one share of Issuer's Common Stock.

F5 · derivative.exercise_date: Restricted Shares Units became payable in shares of Issuer's Common Stock and vested after satisfaction of certain performance based criteria.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 21:48 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 9,838 $17.09 $168,131.42
Disclosure

SEC source: 0001209191-20-015297 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,300

F2 · kind: Represents 9,838 shares withheld for payment of taxes upon vesting of shares previously reported.

Read SEC document
March 01, 2020 Filed Mar 3, 2020 21:48 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionCommon Stock 9,828 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-015297 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,138

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Shares Units that converted into shares of the Issuer's common stock on a one-for-one basis upon vesting.

Read SEC document
February 13, 2020 Filed Feb 18, 2020 23:00 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 49,945 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-010320 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · EVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,310

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 12,487 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2020. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023, subject to the terms of the Plan.

Read SEC document
December 01, 2019 Filed Dec 3, 2019 21:57 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 2,952 $26.12 $77,106.24
Disclosure

SEC source: 0001209191-19-058748 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,365

F1 · kind: Represents 2,952 shares withheld for payment of taxes upon vesting of shares previously reported.

Read SEC document
June 01, 2019 Filed Jun 4, 2019 20:50 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 2,144 $24.66 $52,871.04
Disclosure

SEC source: 0001209191-19-034352 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,317.22

F1 · kind: Represents 2,144 shares withheld for payment of taxes upon vesting of shares previously reported.

Read SEC document
March 07, 2019 Filed Mar 8, 2019 21:41 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 4,608 $30.16 $138,984.19
Disclosure

SEC source: 0001209191-19-018141 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,461.22

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-one (31) separate transactions with prices ranging from $29.95 to $30.57 for an average weighted sales price of $30.1615. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

Read SEC document
February 20, 2019 Filed Feb 22, 2019 21:38 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 1,289 $36.22 $46,690.16
Disclosure

SEC source: 0001209191-19-012605 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,069.22

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in eleven (11) separate transactions with prices ranging from $35.98 to $36.35 for an average weighted sales price of $36.222. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 21:28 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 30,462 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-010161 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,358.22

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 7,615 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

Read SEC document
December 01, 2018 Filed Dec 4, 2018 21:57 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-060908 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,896.22

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. Shares will vest in three installments on December 1, 2019, December 1, 2020 and December 1, 2021.

Read SEC document
June 11, 2018 Filed Jun 13, 2018 20:56 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 18,000 $46.95 $845,058.60
Disclosure

SEC source: 0001209191-18-037500 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,896.22

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $46.8950 to $47.05 for an average weighted sales price of $46.9477. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

Read SEC document
May 24, 2018 Filed May 24, 2018 20:42 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionStock Options (Right to Buy) · Derivative 6,000 $27.72 Strike: $27.72 $166,290.00
Disclosure

SEC source: 0001209191-18-033004 · doc4.xml · derivative · entry 3

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2018 Filed May 24, 2018 20:42 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Tax withholdingCommon Stock 4,143 $46.91 $194,348.13
Disclosure

SEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,896.22

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,857 shares of common stock upon the net exercise of 6,000 stock options with 4,143 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise.

Read SEC document
May 24, 2018 Filed May 24, 2018 20:42 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionCommon Stock 6,000 $27.72 $166,290.00
Disclosure

SEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,039.22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:58 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 13,823 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015769 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,039.22

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 3,456 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will vest in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:36 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantRestricted Shares Units · Derivative 9,828 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-064792 · doc4.xml · derivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,828

Underlying: Common Stock · 9,828 shares

Expires 2020-05-15

F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended.

F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock.

F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:36 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 GrantCommon Stock 8,987 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037278 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,216.22

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
March 15, 2017 Filed Mar 17, 2017 20:23 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 6,517 $70.84 $461,645.38
Disclosure

SEC source: 0001209191-17-021381 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,229.22

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-four (24) separate transactions with prices ranging from $70.69 to $70.96 for an average weighted sales price of $70.8371. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionStock Options (Right to Buy) · Derivative 6,000 $28.55 Strike: $28.55 $171,270.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · derivative · entry 3

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2017-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 SaleCommon Stock 6,000 $69.59 $417,531.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,746.22

F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were sold in twenty (20) separate transactions with prices ranging from $69.50 to $69.72 for a weighted average sales price of $69.5885. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC Pediatrix Medical Group, Inc. MD · Entity 4451 Exercise / conversionCommon Stock 6,000 $28.55 $171,270.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,746.22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.